When do you consider the use of lumateperone to treat schizophrenia spectrum disorders?

It is obscene that these drugs cost $1,400-$1,800/month retail.

Most of the new medications are not available in the CA state system.

I have found that Caplyta has properties similar to quetiapine for sleep and mood irritability in a bipolar type patient with not as much weight gain insulation. I’ve given it to manic patients and had very little efficacy.

I have tried lumateperone for schizophrenia patients in clinical practice, and so far, I have not seen it to be effective. Placebo may work better than this.